Karl G. Blume - Concepedia

Author

Karl G. Blume

Stanford University

Also Known As

A Dumoulin, Blume, Karl, K Blume, K G Blume, K. -G. Blume, K. Blume, K. G. BLUME, K. G. Blume, K.-G. Blume, K.G Blume

227

Publications

16.7K

Citations

H-Index

Concepts

All Affiliations

Stanford University City Of Hope National Medical Center Stanford Medicine Fred Hutch Cancer Center University of Washington

About

Karl G. Blume is an author at Stanford University specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	37	3K
2	Health Sciences	14	16	907
3	Arts	2	2	107
4	Natural Sciences	1	1	21
5	Public Health	1	1	29

Karl G. Blume

110

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, Blood	2001	1.4K
Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers William Bensinger, Paul J. Martin, Barry E. Storer, New England Journal of Medicine	2001	961
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program Nancy A. Kernan, Glenn E. Bartsch, Robert C. Ash, New England Journal of Medicine	1993	848
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission Peter A. Cassileth, David P. Harrington, Frederick R. Appelbaum, New England Journal of Medicine	1998	609
International Committee for Standardization in Haematology: Recommended Methods for Red‐Cell Enzyme Analysis* Ernest Beutler, Karl G. Blume, Josseline Kaplan, British Journal of Haematology British JournalLaboratory HematologyInternational CommitteeMedicineBioanalysis	1977	539
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru, Blood	2003	455
One million haemopoietic stem-cell transplants: a retrospective observational study Aloïs Gratwohl, Marcelo C. Pasquini, Mahmoud Aljurf, The Lancet Haematology TransplantationMarrow TransplantationHaemopoietic Stem-cell TransplantsStem Cell TransplantationHematology	2015	426
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial Mary E.D. Flowers, Pablo Parker, Laura Johnston, Blood	2002	418
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma David G. Maloney, Arthur J. Molina, Firoozeh Sahebi, Blood	2003	406
Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility Study Volker L. Reichardt, Craig Okada, Arcangelo Liso, Blood	1999	390

Page 1